J Biol Chem, Vol. 275, Issue 3, 1749-1756, January 21, 2000
Residues of the Fourth Transmembrane Segments of the
Na,K-ATPase and the Gastric H,K-ATPase Contribute to Cation
Selectivity*
Martin
Mense
§,
Lisa A.
Dunbar
,
Rhoda
Blostein¶, and
Michael J.
Caplan
From the
Department of Cellular and Molecular
Physiology, Yale University School of Medicine,
New Haven, Connecticut 06520-8026 and the
¶ Departments of Medicine and Biochemistry, McGill
University, Montreal, Quebec H3G 1A4, Canada
 |
ABSTRACT |
We have generated protein chimeras to investigate
the role of the fourth transmembrane segments (TM4) of the Na,K- and
gastric H,K-ATPases in determining the distinct cation selectivities of these two pumps. Based on a helical wheel analysis, three residues of
TM4 of the Na,K-ATPase were changed to their H,K-counterparts. A
construct carrying three mutations in TM4 (L319F, N326Y, and T340S) and
two control constructs were heterologously expressed in
Xenopus laevis oocytes and in the pig kidney
epithelial cell line LLC-PK1. Biochemical ATPase assays
demonstrated a large sodium-independent ATPase activity at pH 6.0 for
the pump carrying the TM4 substitutions, whereas the control constructs
exhibited little or no activity in the absence of sodium. Furthermore,
at pH 6.0 the K1/2(Na+)
shifted to 1.5 mM for the TM4 construct compared with 9.4 and 5.9 mM for the controls. In contrast, at pH 7.5 all
three constructs had characteristics similar to wild type Na,K-ATPase.
Large increases in K1/2(K+)
were observed for the TM4 construct compared with the control constructs both in two-electrode voltage clamp experiments in Xenopus oocytes and in ATPase assays. ATPase assays also
revealed a 10-fold shift in vanadate sensitivity for the TM4 construct. Based on these findings, it appears that the three identified TM4
residues play an important role in determining both the specific cation
selectivities and the E1/E2 conformational
equilibria of the Na,K- and H,K-ATPase.
 |
INTRODUCTION |
The P-type class of ion motive ATPases includes the Na,K-, H,K-,
and Ca-ATPases. These molecules couple the energy liberated through ATP
hydrolysis to the transmembrane translocation of cations. Much remains
to be learned about the structural features of these pumps that
determine their functional characteristics.
In this study we take advantage of the high mechanistic and functional
homology relating the gastric H,K-ATPase and the Na,K-ATPase to
investigate the molecular basis for their distinct cation selectivity properties. Both enzymes form functional heterodimers consisting of a
larger
-subunit (~110 kDa) and a highly glycosylated
-subunit (~35 kDa). For both enzymes, the structural determinants required for
enzymatic function have been mapped to the
-subunits, whereas the
-subunits are required to ensure the structural integrity of the
protein and for delivery of the heterodimeric pump complex to the
plasma membrane (for review see Ref. 1). The Na,K-ATPase is ubiquitous,
whereas the gastric H,K-ATPase is primarily found in gastric parietal
cells (2), though it has been detected in the kidney as well (3). The
-subunits of these two P-type ATPases are 62% homologous, and their
hydropathy plots are virtually identical. However, the proteins exhibit
major functional differences. Whereas the Na,K-ATPase exports three
Na+ ions from the cytoplasm to the extracellular side in
exchange for two K+ ions, the H,K-ATPase secretes two
protons in exchange for two potassium ions (1).
The high degree of similarity between the Na,K-ATPase and the gastric
H,K-ATPase allows their functional determinants to be studied through
the generation of chimeras. By exchanging sequence domains and
analyzing the functional properties of the resultant chimeric proteins
it is possible to identify protein segments that are critical for the
different physiological properties of the pumps. We have previously
reported that the N-terminal halves of the
-subunits of the Na,K-
and H,K-ATPases in part determine their distinct ion specificities (4).
The N-terminal half of each
-subunit includes the first four
transmembrane domains
(TM1-TM4)1 as well as half of
the large cytoplasmic loop connecting TM4 and TM5. To analyze this
region further, a chimera was prepared in which the ectodomain between
TM3 and TM4, the fourth transmembrane domain, and the N-terminal half
of the large cytoplasmic loop between TM4 and TM5 (amino acids
309-506)2 of the Na,K-ATPase
-subunit were replaced by the complementary portions of the
H,K-ATPase. The chimera was transfected into polarized LLC-PK1 pig kidney epithelial cells and was found to
accumulate at the apical plasma membrane. When these cells were grown
on permeable filter supports, an ouabain-sensitive acidification of the
medium bathing their apical surfaces was
observed.3 These data suggest
that residues in TM4 and/or its flanking sequences confer the capacity
to mediate proton transport. We were not able to analyze the kinetic
properties of this chimera, because we could not reliably detect
chimera-associated ATPase activity.
To define more precisely these amino residues that are critical for the
cation selectivity, we have begun to characterize chimeras that have
only portions of the Na,K-ATPase sequence between amino acids 309 and
506 replaced by their H,K-counterparts. Recently we have reported that
a chimera comprising the Na,K-ATPase sequence in which the proximal
half of the cytoplasmic loop (amino acids 343-506) is replaced by the
corresponding H,K-ATPase sequence has an altered cation selectivity. In
ATPase assays at pH 6.0 this chimera achieved 28% of its maximal
activity without any added sodium in the assay solution, whereas there
is no detectable sodium-independent activity for the wild type enzyme.
This suggests that protons can substitute for Na+ ions in
the catalytic cycle of the pump (4).
Extensive site-directed mutagenesis studies performed on the Na,K- and
Ca-ATPase indicate that amino acid residues that reside in four of the
predicted transmembrane domains (TM4, TM5, TM6, and TM8) make important
contributions to cation binding. Each of these amphiphatic helices
contains charged and polar residues whose side chains might be expected
to participate in the formation of cation binding sites. Results from
several labs indicate that mutations in the fourth transmembrane domain
of the Ca-ATPase change this pump's apparent affinity for
Ca2+ (for review see Ref. 6). Comparable results have been
obtained for the Na,K-ATPase.
In the present study we dissect further the relevance to cation
selectivity of selected TM4 residues together with the extracellular ectodomain (residues 309-342). The TM4s of the two pumps differ by
only eight amino acid residues. We found that the replacement of only
three Na,K-ATPase residues with their H,K-counterparts (L319F, N326Y,
and T340S) has dramatic effects on pump function. These three mutations
in TM4 together with the exchange of the ectodomains between TM3 and
TM4 yield an ATPase, which at pH 6.0 achieves more than 50% of its
maximal Na,K-ATPase activity in the absence of sodium. A control
construct that only incorporated the ectodomain replacement but not the
mutations in TM4 showed only 13% sodium-independent ATPase activity at
pH 6.0. Our data suggest, therefore, that these three amino residues
play an important role in determining the distinct cation selectivity
properties of the Na,K- and H,K-ATPase.
 |
EXPERIMENTAL PROCEDURES |
Construction and Expression of Chimeras--
The chimeras
presented in this paper were constructed between the rat Na,K-ATPase
1-subunit (cDNA provided by E. Benz, Johns Hopkins
University) and the rat gastric H,K-ATPase
-subunit (cDNA provided by G. Shull, University of Cincinnati). The Kunkel method of
site-directed mutagenesis was used to silently introduce
ApaI, AccI, and HpaI restriction sites
into the two cDNAs. An ApaI site was created in the
Na,K-ATPase to match the site existing in the H,K-ATPase at base pair
465 corresponding to amino acid 85. The AccI and
HpaI sites corresponding to H,K-ATPase amino acids 329 and
356 were introduced into both cDNAs. Chimera H85N was
generated by subcloning the small ApaI fragment of the
H,K-ATPase into the larger ApaI fragment of the Na,K-ATPase.
The ecto and ecto + A chimeras were constructed
by ligating annealed synthetic oligonucleotides between the
AccI and HpaI sites of the H85N
chimera. The oligonucleotide 5'-ATACCTTCCT TCGGGCTGTC ATCTTCCTCA
TTGGTATCAT CGTAGCCAAC GTGCCGGAAG GTTTGCTAGC CACCGTCACG GTATGTCTGA
CGTT-3' and its complementary strand were used for the ecto
chimera. The oligonucleotide 5'-ATACCTTCCT TCGGGCCGTC ATCTTCTTCA
TTGGTATTAT CGTAGCCTAT GTGCCTGAGG GGCTGCTAGC TACTGTCACG GTCTGCCTGT
CGTT-3' and its complementary strand were used for the ecto + A chimera. Construction of the chimeras took place in either the
pBluescript or pSP72 vector (Promega Corp, Madison, WI). Once the
chimeras were sequenced through their ligation points, they were
subcloned into expression vectors suitable for the different expression systems.
For expression in Xenopus oocytes the cDNAs encoding the
constructs were excised from pBluescript using the ClaI and
XbaI restriction sites and ligated into a modified
pBluesript vector using ClaI and SpeI sites. The
modified pBluescript vector, enhanced for Xenopus oocyte
expression, was kindly provided by William Joiner, Yale University. The
polylinker of the vector is flanked by the 5'- and 3'-untranslated
region sequences of Xenopus
-globin. This modification
has been shown to boost mRNA stability and expression levels in
Xenopus oocytes (7). The 5'-untranslated region is inserted
between the KpnI and the ApaI sites of the
pBluescript-KS vector. The 3'-untranslated region plus a poly(A)
sequence was ligated into the vector using the BstEII site
and the BsmI site. For in vitro transcription of
the chimera cDNAs, the vector was linearized with XbaI,
which cuts downstream from the poly(A) sequence. An Ambion T3
mMessage-mMachine kit was used for the transcription reaction. Oocytes
were obtained and treated according to standard methods (8).
Xenopus oocytes were injected with 50 nl of cRNA solution
containing a total of 16 ng of
-subunit and 12 ng of Na,K-ATPase
1-subunit RNA. Oocytes were maintained in ND96 medium supplemented with 5 mM pyruvate and 50 µg/ml gentamycin
(Life Technologies, Inc.). They were used for experiments on day 3 or 4 postinjection.
For expression in LLC-PK1 cells, the chimeric cDNAs
were subcloned behind a cytomegalovirus promoter in the mammalian
expression vector pCB6 (kindly provided by M. Roth, University of Texas
Southwestern), which carries resistance to the antibiotic G418 (Life
Technologies, Inc.). Transfection, antibiotic selection, screening for
expression, and ouabain selection were carried out as described in Ref.
4.
Electrophysiology--
Electrophysiological measurements of pump
currents were performed essentially as described by Horisberger
et al. (9) with the following minor modifications. Prior to
measurements, oocytes were loaded with sodium by incubating them for
2 h at room temperature in a K+- and
Ca2+-free medium (97 mM Na+, 0.82 mM Mg2+, 0.5 mM EGTA, 22.5 mM Cl
, 76 mM gluconate, 10 mM Hepes, pH 7.4). They were subsequently incubated for 15 min in potassium-free bath solution (97 mM Na+,
0.82 mM Mg2+, 0.42 mM
Ca2+, 5 mM Ba2+, 22.5 mM Cl
, 76 mM gluconate, 2 µM ouabain, and 10 mM Hepes, pH 7.4). This solution contains barium to block nonspecific potassium currents and 2 µM ouabain to inhibit endogenous Xenopus
Na,K-ATPase. Finally, oocytes were placed in the chamber of the voltage
clamp setup, which initially contained the same potassium-free bath
solution. Whole cell currents were measured at a holding potential of
50 mV in the following manner: after the baseline had stabilized with
the oocyte in the potassium-free bath, the solution was exchanged for a
potassium-containing solution, and the potassium-induced current was
recorded. The potassium-free and potassium-containing solutions
differed only by the replacement of a fraction of the Na+
ions with K+ ions. The total concentration of
Na+ and K+ was always 97 mM. To
ensure that the observed current was pump-mediated, it was suppressed
by replacing the potassium-containing solution with an identical
solution to which 5 mM ouabain had been added. The data
were obtained using a Warner Instruments Oocyte-Clamp 725C (Warner
Instruments, Hamden, CT) and analyzed with Pulse and Pulsfit software
from HEKA (Darmstadt, Germany). The pump currents were plotted against
the corresponding potassium concentrations and fitted to the Hill
equation,
|
(Eq. 1)
|
where Imax is the maximal or saturated
current, K1/2i is the half
activation constant for the ionic current, [K+] is the
potassium concentration in the bath, and n is the Hill coefficient.
Preparation of Plasma Membranes--
The following procedure was
performed entirely on ice. It has been modified from the method
published by Vilsen (10). After LLC-PK1 cells were grown to
confluence in 10-cm tissue culture dishes, they were washed twice with
phosphate-buffered saline. They were harvested by scraping with a
rubber policeman into 500 µl of a solution containing 250 mM sucrose, 20 mM Tris·HCl, and 1 mM EDTA at pH 7.5. The cells were then sonicated for 1 min
using a Branson Sonifier 250 (Branson, Danbury, CT) at an amplitude of
30% on constant duty cycle. The sonicated membranes were spun in a
Beckman tabletop centrifuge at 3000 × g for 10 min.
The pellet was discarded, and the supernatant was combined with an
equal volume of a solution of 1 M NaI, 5 mM
MgCl2, 20 mM EDTA, and 160 mM Tris
at pH 8.3. This membrane suspension was incubated for 10 min on ice
before the membranes were pelleted by ultracentrifugation at
48,000 × g for 90 min. The supernatant was aspirated,
and the pellet was resuspended and washed in a sodium-free Tris-EDTA
solution (10 mM Tris, 1 mM EDTA, pH 7.4). The
membranes were pelleted a second time by ultracentrifugation and
resuspended in the same sodium-free Tris-EDTA solution. To homogenize
the membrane suspension it was again sonicated for 30 s before the
yield was determined with the Bio-Rad protein assay. The membranes were
frozen at
80 °C until they were used for experiments.
ATPase Assay--
ATPase assays were carried out using a
colorimetric procedure for measuring inorganic phosphate released from
ATP (11, 12). Prior to the assay (except potassium-free assay, see
below), the crude plasma membranes were permeabilized by incubation in
0.65 mg/ml deoxycholic acid, 2 mM EDTA, and 20 mM imidazole for 30 min at room temperature. Assays were
initiated by adding 25 µl of the membrane suspension to a 475-µl
assay solution containing 3 mM MgCl2, 3 mM Tris-ATP, 25 mM imidazole. For sodium
titration experiments the assay solutions also contained 20 mM KCl, NaCl, and
N-methyl-D-glucamine (NMDG). The combined
concentration of NaCl and NMDG was maintained constant at 130 mM to ensure constant ionic strength. For pH titration
experiments, the assay solutions contained 20 mM KCl and
either 130 mM NMDG or 60 mM NaCl and 70 mM NMDG. For vanadate titration experiments the assay
solutions contained 20 mM KCl, 60 mM NaCl, and
70 mM NMDG. The assay solutions for potassium titration
experiments contained 100 mM NaCl, KCl, and NMDG, and the
combined concentration of the latter two ions was constant at 30 mM.
To ensure that each assay measured similar levels of ATPase activity,
different amounts of protein were added to the assay medium, depending
upon the chimera being tested and the pH of the assay medium. Protein
additions were adjusted so that during 2 h of incubation at
37 °C at least 4%, but no more than 10% of the total ATP (3 mM), would be hydrolyzed under Vmax
conditions. Thus, typical total protein added for pH 7.5 assays was
5-8 mg/test tube for H85N and 8-12 mg for ecto
and ecto+A. At pH 6.0 the total protein was increased by
50-100% for each chimera. After 2 h of incubation the reaction
was stopped by adding 1 ml of ice-cold stop solution (0.5 M
HCl, 3% ascorbic acid, 0.5% ammonium molybdate, and 1% SDS), which
was always freshly prepared. All tubes were then transferred to an
ice-cold water bath, and 1.5 ml of a solution with 2% sodium
meta-arsenite, 2% sodium citrate, and 2% acetic acid was added to
each tube. For color development of the phosphate assay the test tubes
were incubated at 37 °C for 10 min. Free inorganic phosphate was
determined by reading the optical density for each test tube at 850 nm
on a Perkin-Elmer Lambda 3B spectrophotometer. In every experiment each
data point was measured in triplicate, and the chimera-specific ATPase
activity was determined as the signal difference from tubes containing
either 10 µM (to inhibit endogenous Na,K-ATPase) or 5 mM ouabain.
Sodium orthovanadate (Sigma) was prepared as an ~10 mM
stock solution at pH 9.0. Prior to the experiments an aliquot was
boiled for at least three minutes, and the vanadate concentration was determined spectrophotometrically at
268 nm (13).
Individual experiments were carried out in triplicates. They were
averaged and normalized to the maximal enzymatic activity (Vmax), which was computed by fitting the data
to a Hill function, V = Vmax/{1 + (K1/2(X+)/[X+])n}.
Each individual experiment was performed at least three times. The data
of the individual experiments were averaged and again fitted to the
Hill function. The values shown are the means of at least three
experiments, and the error bars correspond to the standard deviation
between the values obtained in individual experiments. The data are
presented as percentage of maximal activity
(Vmax). The apparent K1/2
values were also obtained from the same data fits.
Potassium-free Na-ATPase Assays--
Membranes were first
permeabilized in a solution containing 1% bovine serum albumin and
0.65 mg/ml SDS in 15 mM Tris·HCl, pH 7.4, for 10 min at
room temperature, after which they were diluted 50-fold with 0.3%
bovine serum albumin (14). The permeabilized membranes were then
pretreated for 10 min at 37 °C with 0.5 volume of a solution
comprising either 10 mM or 13.3 µM ouabain in
26.7 mM Tris·HCl, pH 7.4, 26.7 mM EGTA-Tris,
16 mM MgSO4, and 5.34 mM EDTA-Tris.
The assay was initiated by adding a 0.25 volume [
-32P]ATP and NaCl (final concentrations, 1 µM and 2 mM, respectively) containing the
indicated final concentrations of vanadate. Assays were carried out as
described by Daly et al. (15), and values shown are the
differences in the averages of two sets of triplicates, the one set
with low (5 µM) ouabain and the other with high (5 mM) ouabain.
 |
RESULTS |
Chimera Design--
As discussed in the introduction, the portion
of the Na,K-ATPase
-subunit residing between TM3 and the fluorescein
isothiocyanate binding site (residues 309-506) appears to be important
in determining cation selectivity. We have previously shown that a
portion of this selectivity is attributable to the sequence domain
bounded by amino acids 343 and 506, which constitutes roughly half of the large cytoplasmic loop connecting transmembrane segments 4 and 5 (Fig. 2A). The goal of this study is to further elucidate the role of residues 309-342 of the Na,K-ATPase in determining the
cation selectivity properties of the pump. These residues comprise the
ectodomain between TM3 and TM4 and all of TM4. Initially, a chimera was
generated that had amino acids 309-342 exchanged for the corresponding
sequence from the H,K-ATPase
-subunit (Fig. 2A). Although
this construct assembles with the
-subunit and is delivered to the
cell surface, no enzymatic activity could be detected (data not shown).
We chose, therefore, to generate new pump constructs incorporating more
narrowly defined substitutions.
Extensive mutagenesis studies have demonstrated that specific residues
of the Ca-ATPase, which is structurally and functionally homologous to
both the Na,K- and H,K-ATPase
-subunits, play a role in cation
binding. Fig. 1A depicts
helical wheel representations of the TM4s of the Na,K- and H,K-ATPase.
Residues marked with asterisks correspond to the positions
of the five Ca-ATPase amino acids (Ala-305, Ala-306, Glu-309, Gly-310,
and Pro-312), which have been shown to play a role in calcium
translocation (6, 16). It is interesting to note that all five residues
are predicted to lie on the same helical face. It would appear,
therefore, that TM4 has two domains or faces, one of which is likely to
be directed toward the presumed ion translocation pore, whereas the
other may face the surrounding lipid domain or adjoining helices. These two putative faces are separated by a dashed line (Fig.
1A).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 1.
Helical wheel representation of the fourth
transmembrane domains (TM4) of the Na,K- and gastric H,K-ATPase
-subunits. Of the 29 amino acids, which are
thought to form TM4, only eight differ between Na,K- and H,K-ATPase.
They are depicted in black bold face. A,
mutational analysis of the Ca-ATPase indicates that the five positions
marked with an asterisk play a role in cation translocation
(6, 16). These five residues reside on the same half of the helix,
suggesting that this helical face might be oriented toward the putative
cation translocation pore of the P-type ATPases. In contrast, the face
on the opposite side of the dashed line might confront
surrounding lipid and adjoining helices. In this study we have replaced
the Na,K residues above the dashed line with their
H,K-counterparts. The resulting mutations are L319F, N326Y, and T340S.
B, the sequences shown in this alignment were used for the
helical wheel analysis shown above.
|
|
Fig. 1B shows a sequence alignment of the TM4s of the Na,K-
and H,K-ATPase
-subunits. The TM4s of Na,K- and H,K-ATPase differ at
only eight amino acid positions marked by the solid black
letters. Of these eight residues, only Leu-319,
Asn-326, and Thr-340 of the sodium pump are located in the domain that
faces the putative ion translocation pore (Fig. 1A). We have
hypothesized, therefore, that these three residues might be intimately
involved in establishing the distinct cation selectivities of the Na,K-
and H,K-pumps. To test this possibility, construct ecto + A
(Fig. 2B) was generated, which
had these three TM4 residues mutated to their H,K-counterparts (L319F,
N326Y, and T340S), and includes the ectodomain between TM3 and TM4.
This ectodomain replacement resulted in two amino acid replacements
compared with the sodium pump sequence, W312F, and E314R (Fig.
2C). To control for a contribution of the ectodomain the
construct ecto was produced, which had only the ectodomain replaced with its H,K-ATPase counterpart (Fig. 2B).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 2.
Schematic diagram of the Na,K-ATPase and
representations of the three constructs employed in this study.
A, the residue numbers indicated in this map of the
Na,K-ATPase correspond to the amino acids that mark segment boundaries
in the chimeric constructs that are mentioned throughout the paper. In
addition, the three TM4 residues that are mutated in construct
ecto + A are indicated. aa, amino acid.
B, the sequences depicted in white are from
Na,K-ATPase, whereas the black domains and residues are from
gastric H,K-ATPase. The construct H85N at the top
is used as the wild type control for this study. The swap of the first
85 amino acids does not produce functional consequences but provides a
useful epitope tag for a specific antibody. This tag is included in all
of the constructs. Construct ecto + A is shown at the
bottom. It contains the three mutations in TM4 (L319F,
N326Y, and T340S), which were indicated in Fig. 1, plus the ectodomain
between TM3 and TM4 from H,K-ATPase. The rationale for the construct
design is explained in the beginning of the result section. Of the six
amino acids comprising this ectodomain only two are different between
the two pumps, resulting in alterations W312F and E314R. Construct
ecto, which is depicted in the middle, serves as
a control for effects introduced by the ectodomain swap. C,
sequence alignment of the ectodomain between TM3 and TM4.
|
|
Finally, for both constructs the first 72 amino acids of the
Na,K-ATPase were replaced with the corresponding H,K-ATPase sequence, which consists of 85 amino acids. An antibody specific to this epitope
allows us to distinguish the chimeric constructs, expressed in
LLC-PK1 cells or Xenopus oocytes, from
endogenous Na,K-ATPase. Previous studies demonstrated that this swap
does not alter the functional properties of the Na,K-ATPase (4). Thus,
construct H85N, which had only the N-terminal replacement,
was used as the "wild type" control throughout the study (Fig.
2).
Measurements of Potassium-induced Ouabain-sensitive Pump
Currents--
A two-electrode voltage clamp of oocytes from
Xenopus laevis was used to assess whether the
chimeric constructs catalyze electrogenic ion fluxes. We took advantage
of the species-dependent differences in ouabain sensitivity
of the Na,K-ATPase to distinguish current driven by the exogenous
recombinant pumps from that mediated by the endogenous sodium pumps of
the oocytes. Because the
1-isoform from rat
(Ki ~ 10
4 M) was used
for the construction of all our chimeras, we could inhibit the
endogenous Na,K-ATPase (Ki ~ 10
7
M) with a low concentration of ouabain (2 µM)
without affecting chimera activity. Under conditions that inhibited the
background potassium currents in the oocytes, all three constructs were
able to produce a potassium-activated outward current (Fig.
3, A-C). This current could
be inhibited by adding 5 mM ouabain, and as expected, the
ouabain block was reversible. We also used this system to determine the
apparent affinities of the chimeric pumps for K+. Clamping
the oocytes at a holding potential of
50 mV, we stepwise increased
the potassium concentration of the bath solution and recorded the
current response (Fig. 3D). The observed plateau currents
were plotted versus the corresponding potassium
concentration. The resulting potassium activation curves allowed
computation of the apparent K1/2 values.
Averaging over four to six different oocytes for each construct and
fitting the data to a Hill function, we found that
K1/2(K+) = 5.6 mM for ecto + A, whereas
K1/2(K+) = 0.56 mM and
K1/2(K+) = 1.16 mM for the controls H85N and ecto,
respectively. Hill coefficients were between 1.5 and 1.7 for all three
constructs. The K1/2 of 5.6 mM for ecto + A represents only a lower
estimate, because the highest K+ concentration employed did
not yield a saturated current. The K1/2
value for H85N corresponds well to what has been reported earlier for the wild type sodium pump under similar ionic conditions (10, 17).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 3.
Potassium dependence of ouabain sensitive
current measured by two-electrode voltage clamp in X. laevis oocytes. The experimental details are
described under "Experimental Procedures." The current trace for a
typical experiment is shown in D. The black bar
represents the interval in which K+ was present in the
bath. The concentrations are given in the figure. The plateau currents
were plotted against the corresponding potassium concentrations, and
the data were fitted to a Hill function as shown in the three other
panels. For H85N (A) the half maximal activation
concentration was computed to be
K1/2c = 0.56 mM,
for ecto (B)
K1/2c = 1.16 mM,
and for ecto + A (C)
K1/2c = 5.6 mM.
All data were normalized averages over at least four different
oocytes.
|
|
ATPase Measurements--
For all of the following experiments
crude plasma membranes from stably transfected LLC-PK1 cells were used.
The LLC-PK1 cell line is derived from pig kidney. Pig
Na,K-ATPase
1 has a Ki for ouabain of
approximately 10
7 M, whereas the
rat-
1, which was used for our constructs, is only
slightly affected by this low concentration of ouabain
(Ki ~ 10
4 M). Thus, at
all times the assay solutions contained a low concentration of ouabain
(10 µM), which is sufficient to inhibit the endogenous but not the exogenous Na,K-ATPase.
Sodium Dependence of the Ouabain-sensitive ATPase--
We assessed
the Na+ dependence of the ATPase activity of our
constructs. The sodium titration experiments were performed both at pH
7.5 and at pH 6. At pH 7.5 the apparent sodium affinities for all three
constructs were not significantly different from what had been reported
for wild type enzyme. The K1/2 for ecto + A was 8.2 mM, for H85N it was 8.3 mM, and for ecto 9.2 mM (Fig. 4). Under similar ionic conditions Vilsen
(10) reported a K1/2(Na+) of 7.1 mM for the wild type enzyme.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 4.
Sodium dependence of ouabain-sensitive ATPase
activity. Sodium titrations of the ATP hydrolysis activity were
carried out at pH 7.5 ( ), and pH 6.0 ( ). The incubation solution
contained 3 mM ATP, 3 mM Mg2+, and
20 mM K+. The endogenous Na,K-ATPase was
inhibited by the addition 10 µM ouabain (for details
refer to "Experimental Procedures"). The data shown are the
averages of at least three independent assays, each of which was
performed in triplicate. A Hill function was employed to model the data
and to compute the K1/2(Na+).
At pH 7.5, K1/2(Na+) for
H85N (A) is found to be 8.4 mM. It is
9.2 mM for ecto (B) and 8.2 mM for ecto + A (C). At pH 6.0 the
K1/2(Na+) for H85N
(A) is 9.5 mM. For ecto
(B) it shifts to 5.6 mM, and for ecto + A (C) a dramatic shift to 1.5 mM is
observed. Furthermore, at pH 6.0 the sodium-independent ATPase activity
of construct ecto + A amounts to 53% of
Vmax. For ecto it is 13%, and for
H85N it is only 7%.
|
|
At pH 6.0 the findings for the ecto + A construct differed
strikingly from those for the controls H85N and
ecto. The apparent K1/2(Na+) for ecto + A
was only 1.5 mM, whereas H85N and
ecto yielded K1/2(Na+)
values of 9.4 and 5.6 mM, respectively. Hill coefficients
were between 1.1 and 1.5. It was especially interesting to note that the ATPase activity for ecto + A in the absence of sodium
was 53% of Vmax, whereas for H85N
the ouabain-sensitive ATPase activity with no sodium added to the
incubation solution was only 5% of maximal. For ecto the
ATPase activity under the same conditions was 13% of
Vmax (Fig. 4). It would appear, therefore, that
at low pH ecto + A can catalyze a substantial
sodium-independent ATPase activity. This observation is consistent with
the possibility that protons can effectively substitute for
Na+ ions in the ecto + A chimera. According to
this interpretation, the apparent decrease in
K1/2(Na+) for ecto + A at
low pH is attributable to protons replacing Na+ ions in the
catalytic cycle of the pump, resulting in the loss of the requirement
for cooperative sodium binding.
pH Dependence of Ouabain-sensitive ATPase--
If, in fact,
protons can substitute for Na+ ions in the catalytic cycle
of ecto + A, we would expect that an increased proton concentration would facilitate its sodium-independent enzymatic activity. To test this hypothesis, we measured the pH dependence of the
sodium-independent ATPase activity. The pH of the assay solution was
varied stepwise by 0.4 pH units (corresponding to a 2.5-fold decrease
in proton concentration). Within a range of pH 6.0 to pH 8.0 for each
pH condition, assays were performed with either 0 or 60 mM
Na+ in the incubation solution. We chose 60 mM
for these experiments based on the results of the sodium titration
experiments (Fig. 4), which demonstrated that this sodium concentration
supports an enzymatic turnover rate close to
Vmax. Comparison of the fraction of
sodium-independent ATPase activity (the ratio of ATPase activity at 0 mM sodium to activity at 60 mM sodium)
indicates that for construct ecto + A the sodium-independent
ATP-hydrolysis increases with increasing proton concentration, whereas
the proton concentration has no significant effect on H85N
and only a small effect on ecto (Fig.
5). For ecto + A, at pH 6.0 the fraction of sodium-independent ATPase activity is again greater
than 50%. These observations further support the hypothesis that the
three residues that are mutated in TM4 of chimera ecto + A
facilitate the substitution of protons for sodium ions in the reaction
cycle of this pump.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 5.
pH dependence of sodium-independent
ouabain-sensitive ATP hydrolysis. The pH dependence of the ATPase
activity was determined with 60 and 0 mM Na+ in
the incubation solution. The solutions also contained 3 mM
ATP, 3 mM Mg2+, 20 mM
K+, and 10 µM ouabain to abolish the
endogenous sodium pump activity (details are given under
"Experimental Procedures"). At 60 mM Na+
the pH dependence of the ATPase activity for all three constructs is
almost identical to what has been observed for wild type Na,K-ATPase
(data not shown). The plot represents the fraction of
sodium-independent ATPase activity at different pH values. A very
strong pH dependence can be seen for construct ecto + A
( ), while the control constructs ecto ( ) and
H85N ( ) show little or no pH dependence. Assays were done
in triplicate, and the data represent averages over at least three
assays.
|
|
Potassium Dependence of Ouabain-sensitive ATPase--
In light of
the large shift in K1/2 for the potassium
activation of pump-mediated current observed in the
electrophysiological experiments (Fig. 3), it was important to
investigate the potassium dependence of the ATPase activity (Fig.
6). At pH 7.5 the
K1/2(K+) for ecto + A was
4.65 mM, whereas for H85N and ecto
K1/2(K+) values were 1.2 and 2.75 mM, respectively. The corresponding K1/2(K+) values at pH 6.0 were 2.47 mM for ecto + A and 0.73 and 1.4 mM
for the H85N and ecto, respectively. Hill
coefficients were in the range of 1.3 to 1.4 for all three constructs.
The apparent affinity values for K+ ions obtained from the
ATPase assays are in reasonably good agreement with those for
K1/2 values determined from the
electrophysiological potassium titrations. Once again, ecto + A manifests a substantially lower K+ affinity than the
other two constructs. The differences in the absolute
K1/2(K+) values obtained in these
two measurements are probably attributable to the different conditions
under which they are performed. The ionic conditions are identical at
the two sides of the permeabilized membranes used for ATPase assays,
whereas it is impossible to control the intracellular milieu of the
intact cells (oocytes) employed in the electrophysiological
determinations.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 6.
Potassium dependence of ouabain-sensitive
ATPase activity. Potassium-dependent ouabain-sensitive
ATPase activity was measured at pH 7.5 ( ) and pH 6.0 ( ). The
incubation solution contained 3 mM ATP, 3 mM
Mg2+, and 100 mM Na+. To inhibit
the endogenous sodium pump all solutions contained 10 µM
ouabain (for details refer to "Experimental Procedures"). Each
assay was performed in triplicate, and for each condition the data
shown are the averages of at least three assays. The data were fitted
to a Hill function. At pH 7.5 the following
K1/2(K+) were computed: for
H85N (A) 1.2 mM, for ecto
(B) 2.8 mM, and for ecto + A
(C) 4.6 mM. At pH 6.0 K1/2(K+) was determined to be
0.74 mM for H85N (A), 1.4 mM for ecto (B), and 2.5 mM for ecto + A (C).
|
|
Vanadate (VO43
) Inhibition of Ouabain-sensitive
ATPase--
It is possible that the observed shifts in apparent
affinity for potassium are due to a change in the steady-state
E1/E2 conformational equilibrium in favor of
E1. To gain insight into this issue, we examined the
inhibition of enzymatic activity by inorganic orthovanadate. Like
inorganic phosphate, orthovanadate acts as a transition state analog,
preferentially binding to the E2 conformation of P-type ATPases to form a relatively stable intermediate (18-20). Thus, if the
ecto + A construct preferentially accumulates in the
E1 conformations, we would expect to observe a larger
IC50 value for vanadate inhibition.
Measurements of the vanadate sensitivities of the two control chimeras,
H85N and ecto, and the ecto + A mutant
were carried out under Vmax conditions at pH 7.5 and 6.0. IC50 values for the vanadate-sensitive component
of ouabain-sensitive ATPase activities were 15, 42, and 151 µM for H85N, ecto, and ecto + A, respectively. At pH 6.0, IC50 values were 26, 61, and 203 µM for H85N, ecto, and
ecto + A, respectively (data not shown). It is interesting that the relationship between the IC50
(VO43+) values obtained for the three
constructs is similar to that observed for the apparent K+
affinities. This finding is consistent with the interpretation that the
conformational equilibrium of the ecto + A construct is
shifted to favor of E1 forms. Finally, it should also be
noted that the IC50 of 15 µM for
H85N corresponds well to observations of the wild type
Na,K-ATPase conducted by Friedrich et al. (21) and Smith
et al. (22).
To rule out the possibility that the changes in vanadate sensitivity
are secondary to changes in K+ affinity, vanadate
titrations were also carried out in the absence of K+.
These titrations were carried out at a low (micromolar) ATP concentration that, in absence of K+, is sufficient to
saturate the ATP binding site and thus enable the accurate
determination of low activity Na-ATPase activity. As shown in Fig.
7, the ~10-fold difference in
sensitivity between ecto and ecto + A persists in
the absence of K+. The IC50 for ecto
was close to that for H85N (not shown).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 7.
Vanadate inhibition titration of
ouabain-sensitive ATPase activity in the absence of potassium. The
assay was carried out in the absence of potassium and in the presence
of 1 µM [ -32P]ATP and 2 mM
NaCl. The solution also contained 5 µM ouabain to
suppress contributions from the endogenous sodium pump (for details see
"Experimental Procedures"). The data illustrate that the large
shift in vanadate IC50 for ecto + A ( )
compared with ecto ( ). Vanadate inhibition of construct
H85N was virtually identical to the inhibition observed for
ecto (not shown). The data shown are a representative single
experiment carried out in triplicate.
|
|
 |
DISCUSSION |
The data presented here demonstrate that residues of the TM4
segments of the Na,K-ATPase and H,K-ATPase
-subunits are important for determining the distinct cation selectivities of these enzymes. A
helical wheel analysis led us to propose that three TM4 residues might
be especially relevant to cation selectivity. A construct ecto + A was generated in which the corresponding residues of H,K-ATPase
-subunit TM4 were substituted into the sequence of Na,K-ATPase
-subunit (L319F, N326Y, and T340S). When the activity of ecto + A was assayed at pH 6.0, it exhibited sodium-independent ATP
hydrolysis, which was more than 50% of its Vmax
activity. This activity was not observed for the wild type-like
H85N construct, and the ecto control construct
had only slightly elevated sodium-independent ATPase activity. The
sodium-independent ATPase activity was strongly pH-dependent, and at pH 7.5 it was not detectable. The
likeliest explanation for the sodium-independent ATPase activity of
ecto + A is that protons can substitute for sodium ions in
this catalytic cycle of the construct. This conclusion is strongly
supported by the pH dependence of the sodium-independent ATP
hydrolysis, which is shown in Fig. 5. An increase in pH from pH 6 to pH
6.4 (corresponding to a 2.5-fold decrease in proton concentration) reduced the sodium-independent ATPase almost 2-fold.
In addition to the sodium-independent ATPase activity observed for
ecto + A, we found that the
K1/2(Na+) for this construct
decreased from 8.2 mM at pH 7.5 to 1.5 mM at pH
6.0 (see Table I). This is kinetically
consistent with a loss, at low pH, of the normal requirement of
Na,K-ATPase for cooperative binding of three sodium ions to drive ATP
hydrolysis and pump turnover. Replacement of one or two Na+
ions by protons in the transport cycle would explain the observed behavior. If at pH 6.0, for example, two internal cation binding sites
were occupied with protons or hydronium ions, the sodium stimulation as
shown in Fig. 4 could reflect the binding of only one sodium ion to the
third, highly specific sodium binding site. Indeed, the
K1/2(Na+) of 1.5 mM is
in reasonably good agreement with K1/2 values
reported by Schneeberger and Apell (23) for the binding of the third sodium ion.
View this table:
[in this window]
[in a new window]
|
Table I
Summary of all K1/2 and IC50 values determined in this
study
All values are given in mM, except for vandate
IC50, which is given in µM. All ATPase activity
experiments were performed in the presence of 3 mM ATP, 3 mM Mg2+, and 10 µM ouabain to inhibit
endogenous Na,K-ATPase. Sodium titrations were performed in the
presence of 20 mM K+, potassium titrations in the
presence of 100 mM Na+, vanadate titrations in the
presence of 20 mM K+ and 100 mM
Na+. Constant ionic strength was ensured by adding appropriate
concentrations of NMDG. For complete details see "Experimental
Procedures."
|
|
In considering the structural basis for the change in the sodium
versus proton selectivity observed with the ecto + A construct, it is tempting to focus on the exchanges L319F and
N326Y, which introduce two bulkier aromatic residues into the presumed
cation translocation pore. The larger side chains of these residues
might be expected to present a greater physical barrier for the binding and transport of the larger sodium ion compared with a proton. The
validity of this argument is, of course, predicated on the extent to
which the ions are hydrated.
In addition to the altered selectivity for sodium versus
protons, a large (5-10-fold) decrease in apparent affinity for
potassium was observed with construct ecto + A in ATPase
assays and in current measurements (Table I). This observation led us
to propose that in addition to altering the cation selectivity, the
substitution of the TM4 residues also leads to a shift in the
E1/E2 conformational equilibrium. Further
experimental evidence supports this interpretation. Thus, the
IC50 shifts that were observed for vanadate inhibition of
the ecto + A construct resemble the shifts observed for
potassium K1/2. It should be noted, however,
that although these findings are consistent with a shift in
conformational equilibrium, they do not constitute rigorous proof of
such an alteration.
We cannot, for example, exclude the possibility that the intrinsic
affinities of the K+ and vanadate binding sites were
altered. Thus, it is possible that the mutation E314R in the ectodomain
between TM3 and TM4 reduces the intrinsic K+ affinity
because the replacement of a negatively charged glutamate with a
positively charged arginine residue might cause a stronger electrostatic repulsion near the access to the extracellular
K+ binding sites. This could explain the small
K1/2(K+) shift observed for the
ecto construct, but the vanadate IC50 shift and
the large K1/2(K+) shift found for
the ecto + A construct are unlikely to be due to a change in
the intrinsic affinities for K+ and vanadate. The shift in
vanadate IC50 persisted in the absence of potassium (Fig.
7), so we can rule out the possibility that it is only secondary to a
change in the intrinsic potassium affinity (24). The possibility that
the vanadate binding site itself has been altered also seems very
unlikely, because none of the mutated residues are part of the presumed
vanadate binding site or are even a close neighbor in the amino acid
sequence. The proposed vanadate binding pocket is very highly conserved
for all P-type ATPases and is thought to correspond to the region
between amino acids 369 to 378 of the Na,K-ATPase (25, 26).
Additional support for a change in the E1/E2
conformational equilibrium comes from the observation that the ouabain
sensitivity of the ecto + A construct is reduced compared
with that of H85N. In the electrophysiological experiments 5 mM ouabain inhibited the current produced by
H85N virtually completely, whereas for ecto + A a
current corresponding to 15-20% of the total potassium-induced current remained in the presence of this drug. None of the residues altered in our study are thought to play a role in ouabain binding. Ouabain predominantly binds to an E2 conformation of the
pump (27). The decreased efficacy of ouabain inhibition might,
therefore, reflect a shift toward E1 conformations with a
concomitant decrease in apparent ouabain affinity.
Unfortunately, technical difficulties associated with the
limited solubility of ouabain have precluded a detailed analysis of the
ouabain effects. Taken together, the behavior of ecto + A
toward K+, VO43+, and
ouabain indicate shifts toward lower apparent affinities for three
different pump ligands, all of which bind to the enzyme in the
E2 conformation. These observations thus constitute strong evidence in favor of a shift in conformational equilibrium.
In a previous mutagenesis study designed to identify residues that
might serve as cation ligands, the asparagine at position 326 of the
Na,K-ATPase was replaced with a leucine residue (28). As a result of
this mutation, the affinity for sodium decreased more than 3-fold to 24 mM, whereas the affinity for potassium did not seem to
change significantly. Further experiments demonstrated that the
decreased sodium affinity was not attributable to a shift in
conformational equilibria. In addition to Asn-326, the residues Glu-329, Glu-781, and Thr-809 have been classified as potential sodium
ligands at the high affinity cytoplasmic sites in the E1 form of the sodium pump (28). Except for Asn-326, these residues are
highly conserved among P-type ATPases, and they are identical between
the Na,K- and gastric H,K-ATPase (1, 29). This would suggest that at
least some of the residues involved in cation binding are shared among
different pumps and do not play a role in determining cation
specificity. It further indicates that Asn-326 may play a critical role
in distinguishing between Na+ ions and protons.
In a recent study of gastric H,K-ATPase and Na,K-ATPase chimeras (4),
it was shown that the N-terminal half of the cytoplasmic loop between
TM4 and TM5 (chimera H85N/H356-519N), and to a greater extent, the
replacement of the entire N-terminal half of the Na,K-ATPase with the
homologous gastric H,K-ATPase domain (chimera H519N) confer marked
increases in selectivity for protons relative to Na+ ions,
even at pH 7.4, when compared with the H85N control. The data presented here demonstrate that residues in TM4 contribute to the
dramatic shift observed with H519N. It seems likely that specificity is
determined through a concerted interaction between the identified
residues in TM4 and sequences within the loop between TM4 and TM5.
Construction of further chimeras will be required to test this
proposition directly.
The results of the present study indicate that transmembrane residues
can also influence conformational equilibria. Similar conclusions can
be drawn from the previous Na,K-/H,K-ATPase chimera studies. Thus, the
H519N but not the H85N/H356-519N displayed reduced vanadate
sensitivity (4). Similarly, Vilsen (5) has shown that the mutation of
Leu-332 to alanine in TM4 of the Na,K-ATPase resulted in a
conformational equilibrium shift toward E1. Perhaps not
surprisingly, therefore, it appears that residues in the transmembrane
domains contribute to the determination of conformational equilibria as
well as participating in the formation of the ion binding and
conduction pathway. Conversely, analysis of the H85N/H356-519N chimera
demonstrates that changes in cation affinities can be produced through
mutations or substitutions outside of predicted transmembrane domains
(4). The small but significant sodium-independent ATPase activity
observed with ecto at low pH is also consistent with the
conclusion that sequences flanking membrane domains can influence
cation selectivity. The mechanism through which these separate domains
of the pump molecules interact to modulate specificity and conformation
remain to be established.
In conclusion, this study elucidates three specific residues of TM4
that are important for the distinct cation selectivity properties of
Na,K- and H,K-ATPases. These residues also impact upon transitions
among the conformational states of these enzymes. Together with our
recent work (4) it becomes evident that cation selectivity of P-type
ATPases is determined not only by transmembrane domains but by an
interplay of transmembrane domains and their flanking regions. These
findings underscore the complex and cooperative nature of cation
translocation by P-type ATPases.
 |
ACKNOWLEDGEMENTS |
We are grateful to Vanathy Rajendran and Ania
Wilczynska for excellent technical support. We are also indebted to
Biff Forbush, Alexander Grishin, Joe Hoffman, and Clifford Slayman for
valuable discussions and advice. Special thanks to Tiffany Runyan
Garrison for reading and critiquing the manuscript.
 |
FOOTNOTES |
*
This work was supported by Grants GM42136 and DR17433 from
the National Institutes of Health and Grant MT-3976 from the Medical Research Council.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Cellular and
Molecular Physiology, Yale School of Medicine, 333 Cedar St., New
Haven, CT 06520. Tel.: (203) 785-6835; Fax: (203) 785-4951; E-mail:
Martin.Mense@yale.edu.
2
In previous publications on Na,K-/H,K-ATPase
chimeras, we have used a numbering system referring to the positions of
gastric H,K-ATPase residues. To facilitate the comparison of the
present results to other mutagenesis studies of the Na,K-ATPase, we
have employed a numbering system based on the Na,K-ATPase sequence in
this manuscript. It should be noted that the Na,K-ATPase amino acid
residues 343-506 correspond to amino acids 356-519 of the H,K-ATPase
in the chimera H85N/H356-519N (4).
3
L. A. Dunbar, P. Aronson, and M. J. Caplan, submitted for publication.
 |
ABBREVIATIONS |
The abbreviations used are:
TM, transmembrane
domain;
NMDG, N-methyl-D-glucamine.
 |
REFERENCES |
| 1.
|
Moller, J. V.,
Juul, B.,
and le Maire, M.
(1996)
Biochim. Biophys. Acta
1286,
1-51[Medline]
[Order article via Infotrieve]
|
| 2.
|
Courtois-Coutry, N.,
Roush, D.,
Rajendran, V.,
McCarthy, J. B.,
Geibel, J.,
Kashgarian, M.,
and Caplan, M. J.
(1997)
Cell
90,
501-510[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Doucet, A.
(1997)
Exp. Nephrol.
5,
271-276[Medline]
[Order article via Infotrieve]
|
| 4.
|
Blostein, R.,
Dunbar, L. A.,
Mense, M.,
Scanzano, R.,
Wilczynska, A.,
and Caplan, M. J.
(1999)
J. Biol. Chem.
274,
18374-18381[Abstract/Free Full Text]
|
| 5.
|
Vilsen, B.
(1997)
Biochemistry
36,
13312-13324[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Andersen, J. P.,
and Vilsen, B.
(1995)
FEBS Lett.
359,
101-106[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Krieg, P. A.,
and Melton, D. A.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
2331-2335[Abstract/Free Full Text]
|
| 8.
|
Fyfe, G. K.,
and Canessa, C. M.
(1998)
J. Gen. Physiol.
112,
423-432[Abstract/Free Full Text]
|
| 9.
|
Horisberger, J. D.,
Jaunin, P.,
Good, P. J.,
Rossier, B. C.,
and Geering, K.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
8397-8400[Abstract/Free Full Text]
|
| 10.
|
Vilsen, B.
(1992)
FEBS Lett.
314,
301-307[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Jorgensen, P. L.,
and Petersen, J.
(1982)
Biochim. Biophys. Acta
705,
38-47[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Ottolenghi, P.
(1975)
Biochem. J.
151,
61-66[Medline]
[Order article via Infotrieve]
|
| 13.
|
Gordon, J. A.
(1991)
Methods Enzymol.
201,
477-482[Medline]
[Order article via Infotrieve]
|
| 14.
|
Forbush, B. D.
(1983)
Anal. Biochem.
128,
159-163[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Daly, S. E.,
Lane, L. K.,
and Blostein, R.
(1994)
J. Biol. Chem.
269,
23944-23948[Abstract/Free Full Text]
|
| 16.
|
MacLennan, D. H.,
Toyofuku, T.,
and Lytton, J.
(1992)
Ann. N. Y. Acad. Sci.
671,
1-10
|
| 17.
|
Kuntzweiler, T. A.,
Wallick, E. T.,
Johnson, C. L.,
and Lingrel, J. B
(1995)
J. Biol. Chem.
270,
2993-3000[Abstract/Free Full Text]
|
| 18.
|
Harris, S. L.,
Perlin, D. S.,
Seto-Young, D.,
and Haber, J. E.
(1991)
J. Biol. Chem.
266,
24439-24445[Abstract/Free Full Text]
|
| 19.
|
Boxenbaum, N.,
Daly, S. E.,
Javaid, Z. Z.,
Lane, L. K.,
and Blostein, R.
(1998)
J. Biol. Chem.
273,
23086-23092[Abstract/Free Full Text]
|
| 20.
|
Ambesi, A.,
Pan, R. L.,
and Slayman, C. W.
(1996)
J. Biol. Chem.
271,
22999-23005[Abstract/Free Full Text]
|
| 21.
|
Friedrich, T.,
Bamberg, E.,
and Nagel, G.
(1996)
Biophys. J.
71,
2486-2500[Abstract/Free Full Text]
|
| 22.
|
Smith, R. L.,
Zinn, K.,
and Cantley, L. C.
(1980)
J. Biol. Chem.
255,
9852-9859[Abstract/Free Full Text]
|
| 23.
|
Schneeberger, A.,
and Apell, H. J.
(1999)
J. Membr. Biol.
168,
221-228[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Sachs, J. R.
(1987)
J. Gen. Physiol.
90,
291-320[Abstract/Free Full Text]
|
| 25.
|
Rao, R.,
and Slayman, C. W.
(1993)
J. Biol. Chem.
268,
6708-6713[Abstract/Free Full Text]
|
| 26.
|
Serrano, R.,
and Portillo, F.
(1990)
Biochim. Biophys. Acta
1018,
195-199[Medline]
[Order article via Infotrieve]
|
| 27.
|
Anner, B. M.,
Moosmayer, M.,
and Imesch, E.
(1994)
Mol. Membr. Biol.
11,
237-245[Medline]
[Order article via Infotrieve]
|
| 28.
|
Vilsen, B.
(1995)
FEBS Lett.
363,
179-183[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Grishin, A. V.,
Sverdlov, V. E.,
Kostina, M. B.,
and Modyanov, N. N.
(1994)
FEBS Lett.
349,
144-150[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles: